{
    "2018-08-16": [
        [
            {
                "time": "",
                "original_text": "QFII、社保、年金、私募二季度都买了啥？中报揭秘它们均买入了这个板块",
                "features": {
                    "keywords": [
                        "QFII",
                        "社保",
                        "年金",
                        "私募",
                        "中报",
                        "买入",
                        "板块"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报: 国家医保局, 14种抗癌药将迎新一轮降价",
                "features": {
                    "keywords": [
                        "医药",
                        "国家医保局",
                        "抗癌药",
                        "降价"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【乐普医疗】中报点评：业绩持续亮眼，多条业务线将陆续迎来收获",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "中报",
                        "业绩",
                        "业务线",
                        "收获"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "巨丰投顾：通讯和国企改革板块发力 沪指2700点底部仍有效",
                "features": {
                    "keywords": [
                        "通讯",
                        "国企改革",
                        "板块",
                        "沪指",
                        "2700点",
                        "底部"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "通讯",
                        "国企改革"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级] 医药生物行业动态：上海带量采购分析 集中招采促进行业升级",
                "features": {
                    "keywords": [
                        "医药生物",
                        "上海",
                        "带量采购",
                        "集中招采",
                        "行业升级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业日报：福建通过一致性评价品种最高补助100万",
                "features": {
                    "keywords": [
                        "医药生物",
                        "福建",
                        "一致性评价",
                        "补助"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}